Sandoz US Subsidiaries Resolve Generic Drug Antitrust Class Action Litigation with Direct Purchaser Class Plaintiffs

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules  MEDIA RELEASE Sandoz US to pay USD 265 million in exchange for full release of all claims by the class Resolves all federal antitrust damages for direct purchaser class plaintiffs’ claims in this litigation, if approved by Court Basel, February 29, 2024 – Sandoz [...]